Tomassen et al introduced that CRS patients could be divided into 3 subgroups with 10 clusters: non-type 2, moderate and severe type 2, in which the latter subgroup showed the highest concentrations of IgE and asthma prevalence.13 This evidence concerns the gene IGHE and asthma.